Drugs used for curing hepatitis C might also help against Covid-19 / World Health Organization publishes paper presented by researchers from Mainz University
“This computer simulation method is known as molecular docking and it has been recognized and used for years. It is much faster and less expensive than lab experiments,” said Professor Thomas Efferth of the JGU Institute of Pharmacy and Biomedical Sciences, lead author of the study. “As far as we know, we were the first to have used molecular docking with SARS-CoV-2. And it is fantastic news that we have found a number of approved hepatitis C drugs as promising candidates for treatment.”
Using the MOGON II supercomputer, the researchers made more than 30 billion single calculations within two months and found that compounds from the four hepatitis C drugs simeprevir, paritaprevir, grazoprevir, and velpatasvir have a high affinity to bind SARS-CoV-2 very strongly and may therefore be able to prevent infection. “This is also supported by the fact that both SARS-CoV-2 and the hepatitis C virus are a virus of the same type, a so-called single-stranded RNA virus,” explained Efferth.
According to the researchers, a natural substance from the Japanese honeysuckle (Lonicera japonica), which has been used in Asia against various other diseases for some time now, might be another strong candidate against SARS-CoV-2. “Our research results now need to be checked in laboratory experiments and clinical studies,” said Efferth and added that molecular docking had already been used successfully in the search for active substances against the coronaviruses MERS-CoV and SARS-CoV.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- The Latest: US Drug Agency Head Vows Vaccine Independenceon June 23, 2020 at 12:52 pm
The head of the U.S. Food and Drug Administration says his agency is maintaining an arm’s-length relationship with a White House-led effort to quickly produce a COVID-19 vaccine once it’s approved.
- NIH director: COVID-19's 'heartbreaking' harm to Black and Hispanic Americans demands testingon June 23, 2020 at 12:42 pm
Francis Collins, director of the NIH, calls COVID-19's harm on Black and Hispanic Americans "heartbreaking" and said trials must reach out to those communities.
- Study: Blood type, genetics may factor in severity of COVID-19 symptomson June 23, 2020 at 12:39 pm
(CNN) - Whether a person gets a severe form of COVID-19 could depend on blood type and their DNA ... Researchers say the findings are more useful for designing drugs or vaccines against coronavirus.
- South Korea’s Genexine begins phase I/IIa trials for COVID-19 vaccineon June 23, 2020 at 12:25 pm
“The COVID-19 vaccine development collaboration is Kalbe's contribution ... between the consortium members and the rapid evaluation of the Ministry of Food and Drug Safety, the trial was approved ...
- US taxpayers are funding six COVID-19 vaccines; Here’s how they workon June 23, 2020 at 12:23 pm
Vaccine vial dose flu shot drug needle syringe ... way to attack the Covid virus Take a look at the virus that causes Covid-19. Focus in on the red spikes. They’re pretty (they look like flowers ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Natural Medicine and Supercomputing Team Up to Combat COVID-19on June 18, 2020 at 3:43 pm
Around the world, supercomputers have been furiously poring over drug compounds to see if any of them could effectively inhibit COVID-19’s insidious spike ...
- Impact Biomedical's COVID-19 research published in peer-reviewed scientific journalon June 18, 2020 at 1:13 am
SGX-listed Singapore eDevelopment Limited's wholly owned subsidiary Impact Biomedical Inc. announced today that their COVID-19 research with Global Research and Discovery Group Sciences, conducted in ...
- Latest findings on bitter substances in coffeeon June 17, 2020 at 9:33 am
Coffee is very popular around the world despite or perhaps because of its bitter taste. Compounds contained in the coffee such as caffeine contribute to the bitterness to varying degrees. A recent ...
- Impact Biomedical Announces Publication of COVID-19 Research in Peer-Reviewed Journalon June 17, 2020 at 4:32 am
SINGAPORE, - (ACN Newswire) - SGX-listed Singapore eDevelopment Limited's (SeD; SGX:40V) wholly owned subsidiary Impact Biomedical Inc. ("Impact ...
- How scientists are using supercomputers to combat COVID-19on June 8, 2020 at 7:30 am
HPC Consortium and its grantees are setting out to understand the novel coronavirus and how it might be tracked, treated, and cured.